Cleared Traditional

K032660 - XTRAK SUPPORT CATHETER

K032660 is an FDA 510(k) clearance for XTRAK SUPPORT CATHETER, manufactured by Xtrak Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 62-day FDA review.

K032660 · Xtrak Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2003
Decision
62d
Days
Class 2
Risk

K032660 is an FDA 510(k) clearance for the XTRAK SUPPORT CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Xtrak Medical, Inc. (Hopkonton, US). The FDA issued a Cleared decision on October 29, 2003 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Xtrak Medical, Inc. devices

FDA 510(k) Submission Details - K032660

510(k) Number K032660 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 28, 2003
Decision Date October 29, 2003
Days to Decision 62 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 125d · This submission: 62d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 729
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K032660.
SCOUT PRO
K033320 · Biotronik, Inc. · Nov 2003
ILT SAFE-CROSS DEFLECTING CATHETER, MODEL C114ND1
K032784 · Intra Luminal Therapeutics, Inc. · Nov 2003
PHERON PTA CATHETER
K033217 · Biotronik, Inc. · Oct 2003
PTA BALLOON CATHETER
K032931 · Cook, Inc. · Oct 2003
ATTAIN 6226DEF DEFLECTABLE CATHETER DELIVERY SYSTEM
K032312 · Medtronic Vascular · Oct 2003
EDWARDS PERIPHERAL DILATATION CATHETER
K032587 · Edwards Lifesciences, LLC · Oct 2003